Companies: 10,795·Total market cap: $144.5T
Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc.

FNCHOTCHealthcare● Active
$7.45
+$0.00(+0.00%)
Market Cap$11962934
P/E Ratio
52W High$16.1
52W Low$2

Finch Therapeutics Group, Inc.(FNCH)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · FNCH · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.02B$0.01B
Cost of Revenue$0.00B$0.00B$0.01B$0.06B$0.03B
Gross Profit($0.00B)($0.00B)($0.00B)($0.04B)($0.03B)
Gross Margin %(computed)-539.61%-209.08%-329.38%
Operating Expenses
R&D Expenses$0.00B$0.01B$0.05B$0.06B$0.03B
G&A Expenses$0.00B$0.03B$0.04B$0.02B$0.01B
Total Operating Expenses$0.02B$0.03B$0.09B$0.08B$0.05B
Operating Income($0.02B)($0.03B)($0.10B)($0.06B)($0.04B)
Operating Margin %(computed)-323.68%-510.90%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.01B)($0.08B)($0.11B)($0.06B)($0.04B)
Income Tax Expense$0.00B($0.00B)$0.00B$0.00B$0.00B
Net Income($0.01B)($0.07B)($0.11B)($0.06B)($0.04B)
Net Margin %(computed)-313.84%-508.46%
Per Share & EBITDA
EPS (Basic)$-8.64$-46.59$-72.12$-36.72$-24.39
Wtd Avg Shares0.00B0.00B0.00B0.00B0.00B
EBITDA($0.01B)($0.03B)($0.08B)($0.06B)($0.04B)
EBITDA Margin %(computed)-311.27%-500.66%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解Finch Therapeutics Group, Inc.

关于Finch Therapeutics Group, Inc.(FNCH)损益表

Finch Therapeutics Group, Inc.(FNCH)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,FNCH实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.01B)(净利率—)。

常见问题

FNCH · 4 问

Finch Therapeutics Group, Inc.(FNCH)2024财年营收为$0.00B,同比down100.0%。

FNCH revenueFNCH salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09